Bill
A 913
Authorizes medical cannabis for treatment of sickle cell anemia.
Bill A 913 allows medical cannabis use for sickle cell anemia patients in New Jersey, offering a new treatment option to alleviate pain and improve quality of life.
Bill
A 913
Bill A 913 allows medical cannabis use for sickle cell anemia patients in New Jersey, offering a new treatment option to alleviate pain and improve quality of life.
WeVote — Public opinion
No community votes yet. Be the first to weigh in from the Vote tab.